Salvati F, Catania F, Murri R, Fantoni M, Torti C
Infez Med. 2024; 32(3):280-291.
PMID: 39282548
PMC: 11392548.
DOI: 10.53854/liim-3203-3.
Carr A, Baliga N, Diener C, Gibbons S
bioRxiv. 2023; .
PMID: 37162960
PMC: 10168307.
DOI: 10.1101/2023.04.28.538771.
Wei S, Jespersen M, Dahl Baunwall S, Myers P, Smith E, Frederik Dahlerup J
Microbiome. 2022; 10(1):193.
PMID: 36352460
PMC: 9647999.
DOI: 10.1186/s40168-022-01394-w.
Ionescu E, Curte A, Olteanu A, Preda C, Tieranu I, Klimko A
Medicina (Kaunas). 2021; 57(7).
PMID: 34356986
PMC: 8307989.
DOI: 10.3390/medicina57070705.
Moron R, Galvez J, Colmenero M, Anderson P, Cabeza J, Rodriguez-Cabezas M
Nutrients. 2019; 11(12).
PMID: 31817895
PMC: 6950228.
DOI: 10.3390/nu11123002.
Laxative Use Does Not Preclude Diagnosis or Reduce Disease Severity in Clostridiodes difficile Infection.
White N, Mendo-Lopez R, Papamichael K, Cuddemi C, Barrett C, Daugherty K
Clin Infect Dis. 2019; 71(6):1472-1478.
PMID: 31584632
PMC: 7486840.
DOI: 10.1093/cid/ciz978.
Two-year analysis of Clostridium difficile ribotypes associated with increased severity.
Herbert R, Hatcher J, Jauneikaite E, Gharbi M, dArc S, Obaray N
J Hosp Infect. 2019; 103(4):388-394.
PMID: 31220480
PMC: 6926500.
DOI: 10.1016/j.jhin.2019.06.003.
Risk, Outcomes, and Trends of Clostridium Difficile Infection in Multiple Myeloma Patients from a Nationwide Analysis.
Ran-Castillo D, Oluwole A, Abuaisha M, Banks Paulino A, Alkhatatneh A, Jang J
Cureus. 2019; 11(4):e4391.
PMID: 31205828
PMC: 6561517.
DOI: 10.7759/cureus.4391.
Risk factors and outcomes of Clostridium difficile infection in hospitalized patients.
Lee H, Hsiao H, Chia C, Cheng C, Tsai T, Deng S
Biomed J. 2019; 42(2):99-106.
PMID: 31130254
PMC: 6541878.
DOI: 10.1016/j.bj.2018.12.002.
Coinfection with 2 Clostridium difficile ribotypes in China: A case report.
Wang L, Luo Y, Huang C, Wu S, Ye J, Song X
Medicine (Baltimore). 2018; 97(13):e9946.
PMID: 29595702
PMC: 5895390.
DOI: 10.1097/MD.0000000000009946.
Toxin positivity and tcdB gene load in broad-spectrum Clostridium difficile infection.
Kim H, Kim H, Moon H, Hur M, Yun Y
Infection. 2017; 46(1):113-117.
PMID: 29218569
DOI: 10.1007/s15010-017-1108-y.
Identifying predictive features of Clostridium difficile infection recurrence before, during, and after primary antibiotic treatment.
Pakpour S, Bhanvadia A, Zhu R, Amarnani A, Gibbons S, Gurry T
Microbiome. 2017; 5(1):148.
PMID: 29132405
PMC: 5684761.
DOI: 10.1186/s40168-017-0368-1.
Real-Time Electronic Tracking of Diarrheal Episodes and Laxative Therapy Enables Verification of Clostridium difficile Clinical Testing Criteria and Reduction of Clostridium difficile Infection Rates.
Truong C, Gombar S, Wilson R, Sundararajan G, Tekic N, Holubar M
J Clin Microbiol. 2017; 55(5):1276-1284.
PMID: 28250001
PMC: 5405247.
DOI: 10.1128/JCM.02319-16.
Burden of Nursing Home-Onset Clostridium difficile Infection in the United States: Estimates of Incidence and Patient Outcomes.
Hunter J, Mu Y, Dumyati G, Farley M, Winston L, Johnston H
Open Forum Infect Dis. 2016; 3(1):ofv196.
PMID: 26798767
PMC: 4719744.
DOI: 10.1093/ofid/ofv196.
